Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
Open Access
- 1 January 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Clinical Microbiology and Antimicrobials
- Vol. 6 (1), 6
- https://doi.org/10.1186/1476-0711-6-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Emerging Infections: In Harm’s Way: Infections in Deployed American Military ForcesClinical Infectious Diseases, 2006
- Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporinsInternational Journal of Antimicrobial Agents, 2006
- In Vivo Development of Ertapenem Resistance in a Patient with Pneumonia Caused by Klebsiella pneumoniae with an Extended-Spectrum -LactamaseClinical Infectious Diseases, 2006
- Extended-Spectrum β-Lactamases and Clinical Outcomes: Current DataClinical Infectious Diseases, 2006
- Extended-spectrum beta-lactamases: the end of cephalosporins?2005
- In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)Journal of Antimicrobial Chemotherapy, 2005
- The New β-LactamasesThe New England Journal of Medicine, 2005
- Role of β-Lactamases and Porins in Resistance to Ertapenem and Other β-Lactams in Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2004
- Extended Spectrum ??-Lactamase (ESBL)-Producing EnterobacteriaceaeDrugs, 2003
- Activity of Ertapenem (MK-0826) versus Enterobacteriaceae with Potent β-LactamasesAntimicrobial Agents and Chemotherapy, 2001